You are accessing SGS's website from the USA.

Would you like to visit the US website?

Share on LinkedInShare on LinkedInShare on FacebookShare on FacebookTweet thisTweet this

Life Sciences


Minimize menuMaximize menu

Minimize menuMaximize menuHomeLife SciencesPharmaceutical ServicesAudit, Certification & VerificationQualityExcipact Certification

Related Links

Excipact Certification

Excipact certification services from SGS – ensure patient safety through supplier quality.

Pharmaceutical excipient certification, through Excipact™ accreditation, is a voluntary international scheme to provide independent third party certification of manufacturers, suppliers and distributors of pharmaceutical excipients worldwide.

Excipact certification enables you to demonstrate that your operations meet the minimum Good Manufacturing Practice (GMP) and/or Good Distribution Practice (GDP) requirements for excipients. It also enables you to verify the compliance of other actors in the supply chain, reducing the need for duplicate audits saving you both time and money. Accepted by all major stakeholders including relevant authorities globally - European Union (EU), US Food and Drug Administration (FDA), UK Medicines and Healthcare products Regulatory Authority (MHRA) - it is not however a substitute for regulatory inspection, where required.

With a global network of experienced auditors we can assess your operation against the standard and on successful completion approve your Excipact certification, giving access to:

  • A safer, more reliable and transparent pharmaceutical supply chain
  • Cost savings by reducing the audit burden for both customer and supplier without sacrificing quality

The Falsified Medicines Directive in Europe places express requirements on Marketing Authorization Holders (MAH) to assess the GMP used in the manufacture and GDP used in the distribution of excipients by third parties. Organizations achieving Excipact certification can give their clients access to their audit report, as well as any ongoing surveillance activity, fulfilling this requirement. There are similar requirements from the FDA in the USA.

Find out how our pharmaceutical excipient certification services can help your business; contact your local SGS office today.

Email us


SGS Headquarters

  • 1 Place des Alpes
    P.O. Box 2152
    1211 Geneva 1
  • t   +41 22 739 91 11
  • f   +41 22 739 98 86
  • e   Email us


Sign up to SGS publications and newsletters from your region and around the world.

Office Directory

Find SGS offices and labs around the world.World map
Office Locator